Status | Study |
Recruiting |
Study Name: Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer Condition: Refractory Hurthle Cell Thyroid Cancer Date: 2014-05-19 Interventions: Drug: sorafenib Given PO |
Completed |
Study Name: Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment Condition: Malignant Struma Ovarii Papillary Thyroid Cancer Date: 2011-09-24 |
Recruiting |
Study Name: IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients Condition: Thyroid Cancer Date: 2011-07-06 Interventions: Radiation: I131 1.1 GBq Radio-iodine Other Name: Sod |
Completed |
Study Name: A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors Condition: Papillary Thyroid Cancer Follicular Thyroid Cancer Date: 2010-03-22 Interventions: Drug: rosiglitazone one 4 mg d |
Completed |
Study Name: A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer Condition: Thyroid Cancer Date: 2005-07-12 Interventions: Drug: AMG 706 |
Recruiting |
Study Name: Studies on Tumors of the Thyroid Condition: Hurthle Cell Thyroid Cancer Tall Cell Variant Thyroid Cancer Date: 1999-11-03 |